Dr. Brian Hill is the Director of the Lymphoid Malignancies Program and a Staff Physician in the Cleveland Clinic Taussig Cancer Institute. He is the principal investigator of multiple on-going clinical trials of new cancer treatments including novel cellular therapies and has published over 150 research articles pertaining to these topics. He serves as the Chairman of the Pharmacy & Therapeutics (P&T) Committee within the Department of Hematology and Medical Oncology, Co-Director of the Lymphoid Malignancies Center of Excellence and serves on the editorial board of several peer-reviewed journals. He is an Associate Professor of Medicine of the Cleveland Clinic Lerner College of Medicine is an active member of the Case Comprehensive Cancer Center, American Society of Hematology (ASH), and the Center for International Blood and Marrow Transplant Research (CIBMTR).
